BillionToOne (BLLN) Non-Current Deffered Revenue (2025)
BillionToOne (BLLN) posted Non-Current Deffered Revenue of $1.3 million for Q4 2025.
BillionToOne (BLLN) Non-Current Deffered Revenue (2025) Analysis & Trends
BillionToOne has reported Non-Current Deffered Revenue for 1 years, with the latest figure at $1.3 million in Q4 2025.
- Quarterly Non-Current Deffered Revenue changed N/A year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (changed N/A YoY) and the FY2025 annual result came in at $1.3 million, changed N/A from the prior year.
- Non-Current Deffered Revenue was little changed at $1.3 million in Q4 2025 per BLLN's latest filing.
- Over five years, Non-Current Deffered Revenue peaked at $1.3 million in Q4 2025 and troughed at $1.3 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 16.07 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 32.59 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | BillionToOne | 4.42 Bn | 3.87 Bn | 77.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.30 Mn |